Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trough versus AUC monitoring of cyclosporine in allogeneic stem cell transplant recipients
NL-OMON39871Recruiting
- Sponsor
- VU University Medical Center
- Start
- Feb 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, single-blind trial of cyclosporine in hematopoietic malignancies (2 arms), sponsored by VU University Medical Center. Primary endpoints: Grade acute kidney injury, Grade nausea and 1 more. Started Feb 2014; status: recruiting.
02
Drugs
cyclosporine
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on NL-OMON39871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39871.